Shanghai Pioneer Holding Ltd (HKG:1345)

Market Cap	2.46B +3.4%
Revenue (ttm)	1.43B -8.9%
Net Income	142.06M +18.3%
EPS	0.12 +19.4%
Shares Out	1.16B
PE Ratio	17.16
Forward PE	n/a
Dividend	0.12 (5.89%)
Ex-Dividend Date	Nov 19, 2026

Volume	5,000
Open	2.120
Previous Close	2.120
Day's Range	2.120 - 2.120
52-Week Range	1.880 - 2.400
Beta	-0.16
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 27, 2026

About Shanghai Pioneer Holding

Shanghai Pioneer Holding Ltd, an investment holding company, engages in marketing, promotion, and channel management of pharmaceutical products and medical devices primarily in the People’s Republic of China. It offers pharmaceutical products for ophthalmology, pain management, cardiovascular, immunology, gynecology, gastroenterology, and other therapeutic areas; and medical devices, including ophthalmology, orthopedics, odontology, and wound care products. The company also engages in the sale of ancillary tools, and imported in-licensed prescr...

• Industry: Pharmaceutical Retailers
• Sector: Healthcare
• Founded: 1996
• Employees: 448
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1345

Financial Performance

In 2025, Shanghai Pioneer Holding's revenue was 1.28 billion, a decrease of -16.17% compared to the previous year's 1.53 billion. Earnings were 114.38 million, a decrease of -24.56%.

Financial numbers in CNY

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 2, 2026

Data Sources Report a data error